Use and misuse of common terminology criteria for adverse events in cancer clinical trials

BACKGROUND: Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAE v3.0) were released in 2003 and have been used widely to report toxicity in publications or presentations describing cancer clinical trials. Here we evaluate whether guidelines for reporting toxicity are followed in publi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Liang, Fei, Tannock, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932726/
https://www.ncbi.nlm.nih.gov/pubmed/27377548
http://dx.doi.org/10.1186/s12885-016-2408-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932726/
https://www.ncbi.nlm.nih.gov/pubmed/27377548
http://dx.doi.org/10.1186/s12885-016-2408-9

Ejemplares similares